Cargando…

An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics

FabF (3‐oxoacyl‐[acyl‐carrier‐protein] synthase 2), which catalyses the rate limiting condensation reaction in the fatty acid synthesis II pathway, is an attractive target for new antibiotics. Here, we focus on FabF from P. aeruginosa (PaFabF) as antibiotics against this pathogen are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Espeland, Ludvik Olai, Georgiou, Charis, Klein, Raphael, Bhukya, Hemalatha, Haug, Bengt Erik, Underhaug, Jarl, Mainkar, Prathama S., Brenk, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518799/
https://www.ncbi.nlm.nih.gov/pubmed/34189850
http://dx.doi.org/10.1002/cmdc.202100302
_version_ 1784584308912029696
author Espeland, Ludvik Olai
Georgiou, Charis
Klein, Raphael
Bhukya, Hemalatha
Haug, Bengt Erik
Underhaug, Jarl
Mainkar, Prathama S.
Brenk, Ruth
author_facet Espeland, Ludvik Olai
Georgiou, Charis
Klein, Raphael
Bhukya, Hemalatha
Haug, Bengt Erik
Underhaug, Jarl
Mainkar, Prathama S.
Brenk, Ruth
author_sort Espeland, Ludvik Olai
collection PubMed
description FabF (3‐oxoacyl‐[acyl‐carrier‐protein] synthase 2), which catalyses the rate limiting condensation reaction in the fatty acid synthesis II pathway, is an attractive target for new antibiotics. Here, we focus on FabF from P. aeruginosa (PaFabF) as antibiotics against this pathogen are urgently needed. To facilitate exploration of this target we have set up an experimental toolbox consisting of binding assays using bio‐layer interferometry (BLI) as well as saturation transfer difference (STD) and WaterLOGSY NMR in addition to robust conditions for structure determination. The suitability of the toolbox to support structure‐based design of FabF inhibitors was demonstrated through the validation of hits obtained from virtual screening. Screening a library of almost 5 million compounds resulted in 6 compounds for which binding into the malonyl‐binding site of FabF was shown. For one of the hits, the crystal structure in complex with PaFabF was determined. Based on the obtained binding mode, analogues were designed and synthesised, but affinity could not be improved. This work has laid the foundation for structure‐based exploration of PaFabF.
format Online
Article
Text
id pubmed-8518799
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85187992021-10-21 An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics Espeland, Ludvik Olai Georgiou, Charis Klein, Raphael Bhukya, Hemalatha Haug, Bengt Erik Underhaug, Jarl Mainkar, Prathama S. Brenk, Ruth ChemMedChem Full Papers FabF (3‐oxoacyl‐[acyl‐carrier‐protein] synthase 2), which catalyses the rate limiting condensation reaction in the fatty acid synthesis II pathway, is an attractive target for new antibiotics. Here, we focus on FabF from P. aeruginosa (PaFabF) as antibiotics against this pathogen are urgently needed. To facilitate exploration of this target we have set up an experimental toolbox consisting of binding assays using bio‐layer interferometry (BLI) as well as saturation transfer difference (STD) and WaterLOGSY NMR in addition to robust conditions for structure determination. The suitability of the toolbox to support structure‐based design of FabF inhibitors was demonstrated through the validation of hits obtained from virtual screening. Screening a library of almost 5 million compounds resulted in 6 compounds for which binding into the malonyl‐binding site of FabF was shown. For one of the hits, the crystal structure in complex with PaFabF was determined. Based on the obtained binding mode, analogues were designed and synthesised, but affinity could not be improved. This work has laid the foundation for structure‐based exploration of PaFabF. John Wiley and Sons Inc. 2021-08-06 2021-09-06 /pmc/articles/PMC8518799/ /pubmed/34189850 http://dx.doi.org/10.1002/cmdc.202100302 Text en © 2021 The Authors. ChemMedChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Full Papers
Espeland, Ludvik Olai
Georgiou, Charis
Klein, Raphael
Bhukya, Hemalatha
Haug, Bengt Erik
Underhaug, Jarl
Mainkar, Prathama S.
Brenk, Ruth
An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title_full An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title_fullStr An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title_full_unstemmed An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title_short An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics
title_sort experimental toolbox for structure‐based hit discovery for p. aeruginosa fabf, a promising target for antibiotics
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518799/
https://www.ncbi.nlm.nih.gov/pubmed/34189850
http://dx.doi.org/10.1002/cmdc.202100302
work_keys_str_mv AT espelandludvikolai anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT georgioucharis anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT kleinraphael anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT bhukyahemalatha anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT haugbengterik anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT underhaugjarl anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT mainkarprathamas anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT brenkruth anexperimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT espelandludvikolai experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT georgioucharis experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT kleinraphael experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT bhukyahemalatha experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT haugbengterik experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT underhaugjarl experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT mainkarprathamas experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics
AT brenkruth experimentaltoolboxforstructurebasedhitdiscoveryforpaeruginosafabfapromisingtargetforantibiotics